Taken together, our observations suggested that miR-9 plays a tumor suppressor role in HCC, partially via targeting IGF2BP1 to inhibit ERK and AKT oncogenic pathways. The gene discussed is IGF2BP1; the disease is hepatocellular carcinoma.